WASHINGTON, March 30 -- Food and Drug Administration has issued a notice called: Incorporating Voluntary Patient Preference Information Over the Total Product Life Cycle; Guidance for Industry, Food and Drug Administration Staff, and Other Interested Parties; Availability.
The notice was published in the Federal Register on March 30 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle." Patients provide valuable input to FDA in a variety of forms. This guidance describes the principles and concep...